Preventive Care in Nursing and Midwifery
Volume 16, Issue 3 (7-2026)
Prev Care Nurs Midwifery 2026, 16(3): 0-0 |
Back to browse issues page
Ethics code: IR.AJUMS.REC.1401.595
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rajabi Pour S, Shami M, Javadnoori M, BabaAhmadi A, Javadnoori A, Safaii Pour M et al . Prevalence and Associated Factors of Anabolic-Androgenic Steroid Abuse Among Male Athletes in Ahvaz, Iran: A Cross-Sectional Study. , Prev Care Nurs Midwifery. 2026; 16 (3)
URL: http://nmcjournal.zums.ac.ir/article-1-1023-en.html
URL: http://nmcjournal.zums.ac.ir/article-1-1023-en.html
Saba Rajabi Pour 
, Maryam Shami , Mojgan Javadnoori * , Azar BabaAhmadi , Amir Javadnoori , Mohammad Safaii Pour , Milad Sedaghati Pour
, Maryam Shami , Mojgan Javadnoori * , Azar BabaAhmadi , Amir Javadnoori , Mohammad Safaii Pour , Milad Sedaghati Pour
Reproductive Health Promotion Research Center, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran , mojganjavadnoori@gmail.com
Abstract: (532 Views)
Background: Anabolic‑androgenic steroid (AAS) use is prevalent among athletes, yet its relationship with body image and other characteristics remains insufficiently understood.
Objectives: This study examined the prevalence of AAS abuse and its association with body image among male athletes.
Methods: This cross-sectional study included 300 male athletes aged ≥15 years in Ahvaz, Iran, recruited through multistage sampling between March 2023 and January 2024. AAS abuse was defined as nonmedical use of anabolic-androgenic steroids without a physician's prescription or for performance‑ or appearance-enhancing purposes during the previous five years. Data were collected using a structured online questionnaire covering demographic characteristics and AAS use, together with the Multidimensional Body-Self Relations Questionnaire (MBSRQ). Statistical analyses were performed using the Mann–Whitney U and chi-square tests in SPSS version 25.
Results: AAS use was reported by 19.3% of participants. Intramuscular injections were the most common route of administration, and Sustanon was the most frequently used agent. The mean (SD) MBSRQ total score was significantly lower among AAS users than non‑users [220.03 (29.22) vs. 234.45 (21.43), p < 0.001]. AAS use was associated with place of residence (p = 0.012), weekly gym attendance (p = 0.007), supplement use (p < 0.001), illicit drug use (p < 0.001), and training‑session duration (p = 0.020). No significant associations were found with age or education level (p > 0.05).
Conclusion: Nearly one in five athletes reported AAS use. Users had lower MBSRQ scores than non‑users, indicating differences in body image between the groups. AAS use was also related to several training and substance‑use characteristics.
Objectives: This study examined the prevalence of AAS abuse and its association with body image among male athletes.
Methods: This cross-sectional study included 300 male athletes aged ≥15 years in Ahvaz, Iran, recruited through multistage sampling between March 2023 and January 2024. AAS abuse was defined as nonmedical use of anabolic-androgenic steroids without a physician's prescription or for performance‑ or appearance-enhancing purposes during the previous five years. Data were collected using a structured online questionnaire covering demographic characteristics and AAS use, together with the Multidimensional Body-Self Relations Questionnaire (MBSRQ). Statistical analyses were performed using the Mann–Whitney U and chi-square tests in SPSS version 25.
Results: AAS use was reported by 19.3% of participants. Intramuscular injections were the most common route of administration, and Sustanon was the most frequently used agent. The mean (SD) MBSRQ total score was significantly lower among AAS users than non‑users [220.03 (29.22) vs. 234.45 (21.43), p < 0.001]. AAS use was associated with place of residence (p = 0.012), weekly gym attendance (p = 0.007), supplement use (p < 0.001), illicit drug use (p < 0.001), and training‑session duration (p = 0.020). No significant associations were found with age or education level (p > 0.05).
Conclusion: Nearly one in five athletes reported AAS use. Users had lower MBSRQ scores than non‑users, indicating differences in body image between the groups. AAS use was also related to several training and substance‑use characteristics.
Type of Study: Orginal research |
Subject:
other
References
1. Bonnecaze AK, O'Connor T, Aloi JA. Characteristics and attitudes of men using anabolic androgenic steroids (AAS): a survey of 2385 men. American Journal of Men's Health. 2020;14(6):1557988320966536. [https://doi.org/10.1177/1557988320966536] [PMID]
2. Linhares BL, Miranda EP, Cintra AR, Reges R, Torres LO. Use, misuse and abuse of testosterone and other androgens. Sexual Medicine Reviews. 2022;10(4):583-595. [https://doi.org/10.1016/j.sxmr.2021.10.002] [PMID]
3. Ding JB, Ng MZ, Huang SS, Ding M, Hu K. Anabolic-androgenic steroid misuse: mechanisms, patterns of misuse, user typology, and adverse effects. Journal of Sports Medicine. 2021;2021:7497346. [https://doi.org/10.1155/2021/7497346] [PMID]
4. Selk-Ghaffari M, Shab-Bidar S, Halabchi F. The prevalence of anabolic-androgenic steroid misuse in Iranian athletes: a systematic review and meta-analysis. Iranian Journal of Public Health. 2021;50(6):1120-1134. [https://doi.org/10.18502/ijph.v50i6.6411] [PMID]
5. Nakhaee MR, Pakravan F, Nakhaee N. Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of Iran. Addiction & Health. 2013;5(3-4):77-82. [https://pmc.ncbi.nlm.nih.gov/articles/PMC3905478/]
6. Khalili S, Khoshravesh S, Barati M, Mahjoub H, Faradmal J. Androgenic-anabolic steroid use among bodybuilders in western Iran: application of ridge logistic regression model. BMC Sports Science, Medicine and Rehabilitation. 2023;15(1):7. [https://doi.org/10.1186/s13102-023-00616-4] [PMID]
7. de Ronde W, Smit DL. Anabolic androgenic steroid abuse in young males. Endocrine Connections. 2020;9(4):R102-R111. [https://doi.org/10.1530/EC-19-0557] [PMID]
8. Desai A, Yassin M, Cayetano A, Tharakan T, Jayasena CN, Minhas S. Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS). Therapeutic Advances in Urology. 2022;14:17562872221105017. [https://doi.org/10.1177/17562872221105017] [PMID]
9. Ahmed MH, Al-Saud NS, Omar AM, Magadmi RM, Hassan SM, Al-Qudsi FM. Knowledge of and attitudes toward the use of anabolic-androgenic steroids among the population of Jeddah, Saudi Arabia. Journal of Microscopy and Ultrastructure. 2019;7(2):78-83. [https://doi.org/10.4103/JMAU.JMAU_64_18] [PMID]
10. Fett WCR, Maruyama M, Brandao C, Fett W. Blood biochemical markers of competitive bodybuilding athletes users of anabolic androgenic steroids and/or growth hormone (AAS/GH), strength athletes, drug-free, and sedentary persons. International Journal of Sports Science. 2018;8(1):1-7. [https://doi.org/10.5923/j.sports.20180801.01]
11. Saeidinejat S, Hooshmand E, Zahra H, Vafaee Najar A. Evaluating the pattern of anabolic androgenic steroid use and its relation with mental health of male members of bodybuilding clubs of Iran, in 2015. Asian Journal of Sports Medicine. 2018;9(1):e60164. [https://doi.org/10.5812/asjsm.60164]
12. Althobiti SD, Alqurashi NM, Alotaibi AS, Alharthi TF, Alswat KA. Prevalence, attitude, knowledge, and practice of anabolic androgenic steroid (AAS) use among gym participants. Materia Socio-Medica. 2018;30(1):49-52. [https://doi.org/10.5455/msm.2018.30.49-52] [PMID]
13. Reyes-Vallejo L. Current use and abuse of anabolic steroids. Actas Urológicas Españolas (English Edition). 2020;44(5):309-313. [https://doi.org/10.1016/j.acuroe.2019.10.007]
14. Skauen JE, Pallesen S, Bjørnebekk A, Chegeni R, Syvertsen A, Petróczi A, et al. Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis. Current Opinion in Endocrinology, Diabetes and Obesity. 2023;30(6):309-323. [https://doi.org/10.1097/MED.0000000000000822] [PMID]
15. Liu M, Yu Y. Adverse effects of anabolic androgenic steroid abuse in athletes and physically active individuals: a systematic review and meta-analysis. Substance Use & Misuse. 2025;60(6):873-887. [https://doi.org/10.1080/10826084.2025.2460986] [PMID]
16. Havnes IA, Bukten A, Rognli EB, Muller AE. Use of anabolic-androgenic steroids and other substances prior to and during imprisonment: results from the Norwegian Offender Mental Health and Addiction (NorMA) study. Drug and Alcohol Dependence. 2020;217:108255. [https://doi.org/10.1016/j.drugalcdep.2020.108255] [PMID]
17. Christou MA, Christou PA, Markozannes G, Tsatsoulis A, Mastorakos G, Tigas S. Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: a systematic review and meta-analysis. Sports Medicine. 2017;47(9):1869-1883. [https://doi.org/10.1007/s40279-017-0709-z] [PMID]
18. Jiotsa B, Naccache B, Duval M, Rocher B, Grall-Bronnec M. Social media use and body image disorders: association between frequency of comparing one's own physical appearance to that of people being followed on social media and body dissatisfaction and drive for thinness. International Journal of Environmental Research and Public Health. 2021;18(6):2880. [https://doi.org/10.3390/ijerph18062880] [PMID]
19. Youseflu S, Rostami F, Yousefi Afrashteh M, Bayat Z, Rastegari L. The effect of body image satisfaction on women's sexual function in postpartum period. Preventive Care in Nursing and Midwifery Journal. 2019;8(4):27-31. [https://doi.org/10.29252/pcnm.8.4.27]
20. Ferrer-Urbina R, Sepúlveda-Páez GL, Henríquez DT, Acevedo-Castillo DI, Llewellyn-Alvarado DA. Development and validity evidence of the multidimensional scale of sexual self-concept in a Spanish-speaking context. Psicologia, Reflexão e Crítica: Revista Semestral do Departamento de Psicologia da UFRGS. 2019;32:22. [https://doi.org/10.1186/s41155-019-0136-1] [PMID]
21. Ahuja L, Schneider J, Budhraja M, Diedrichs PC, Williamson H. A systematic review exploring the effectiveness of body image interventions among boys. Adolescent Research Review. 2025;10(1):97-143. [https://doi.org/10.1007/s40894-024-00246-y]
22. Abdoli M, Scotto Rosato M, Desousa A, Cotrufo P. Cultural differences in body image: a systematic review. Social Sciences. 2024;13(6):305. [https://doi.org/10.3390/socsci13060305]
23. Al-Harbi FF, Gamaleddin I, Alsubaie EG, Al-Surimi KM. Prevalence and risk factors associated with anabolic-androgenic steroid use: a cross-sectional study among gym users in Riyadh, Saudi Arabia. Oman Medical Journal. 2020;35(2):e110. [https://doi.org/10.5001/omj.2020.28] [PMID]
24. Cash TF. Multidimensional body-self relations questionnaire (MBSRQ). In: Wade T, editor. Encyclopedia of Feeding and Eating Disorders. Singapore: Springer; 2017. p. 551-555. [https://doi.org/10.1007/978-981-287-104-6_3]
25. Shemshadi H, Shams A, Sahaf R, Shamsipour Dehkordi P, Zareian H, Moslem AR. Psychometric properties of Persian version of the Multidimensional Body-Self Relations Questionnaire (MBSRQ) among Iranian elderly. Iranian Journal of Ageing. 2020;15(3):298-311. [https://doi.org/10.32598/sija.15.3.61.13]
26. Sepehri G, Mousavi Fard M, Sepehri E. Frequency of anabolic steroids abuse in bodybuilder athletes in Kerman City. Addiction & Health. 2009;1(1):25-29. [https://pmc.ncbi.nlm.nih.gov/articles/PMC3905495/]
27. de Siqueira Nogueira FR, de Freitas Brito A, de Oliveira CVC, Vieira TI, Beniz Gouveia RL. Anabolic-androgenic steroid use among Brazilian bodybuilders. Substance Use & Misuse. 2014;49(9):1138-1145. [https://doi.org/10.3109/10826084.2014.912062] [PMID]
28. Alsaeed I, Alabkal JR. Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait: a cross-sectional study. Substance Abuse Treatment, Prevention, and Policy. 2015;10:33. [https://doi.org/10.1186/s13011-015-0030-5] [PMID]
29. Hearne E, Wazaify M, Van Hout MC, Atkinson A, McVeigh J. Anabolic-androgenic steroid use in the Eastern Mediterranean region: a scoping review of extant empirical literature. International Journal of Mental Health and Addiction. 2021;19(4):1162-1189. [https://doi.org/10.1007/s11469-019-00217-8]
30. Chan DKC, Dimmock JA, Donovan RJ, Hardcastle S, Lentillon-Kaestner V, Hagger MS. Self-determined motivation in sport predicts anti-doping motivation and intention: a perspective from the trans-contextual model. Journal of Science and Medicine in Sport. 2015;18(3):315-322. [https://doi.org/10.1016/j.jsams.2014.04.001] [PMID]
31. Angoorani H, Halabchi F. The misuse of anabolic-androgenic steroids among Iranian recreational male bodybuilders and their related psycho-socio-demographic factors. Iranian Journal of Public Health. 2015;44(12):1662-1669. [https://pmc.ncbi.nlm.nih.gov/articles/PMC4724739/]
32. Alharbi FF, Gamaleddin I, Alharbi SF, Almodayfer O, Allohidan F, Alghobain M, et al. Knowledge, attitudes and use of anabolic-androgenic steroids among male gym users: a community-based survey in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal. 2019;27(2):254-263. [https://doi.org/10.1016/j.jsps.2018.11.007] [PMID]
33. Tavares ASR, Carolino E, Rosado A, Calmeiro L, Serpa S. Characteristics of gym-goers' performance-enhancing substance use. Sustainability. 2022;14(5):2868. [https://doi.org/10.3390/su14052868]
34. Di Girolamo FG, Biasinutto C, Mangogna A, Fiotti N, Vinci P, Pisot R, et al. Metabolic consequences of anabolic steroids, insulin, and growth hormone abuse in recreational bodybuilders: implications for the World Anti-Doping Agency passport. Sports Medicine - Open. 2024;10(1):28. [https://doi.org/10.1186/s40798-024-00697-6] [PMID]
35. Razavi Z, Moeini B, Shafiei Y, Bazmamoun H. Prevalence of anabolic steroid use and associated factors among bodybuilders in Hamadan, Western Province of Iran. Journal of Research in Health Sciences. 2014;14(2):163-166. [https://doi.org/10.34172/JRHS141255]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |